Eric Ruderman, MD, discusses the prevalence and impact of osteoarthritis and current best practices for treatment and pain mitigation.
This content is supported by an independent education grant funded by Pfizer, Inc., in partnership with Lilly USA, LLC.
Disclosures
Author, Presenter
Eric M. Ruderman, MD
Consultantship: Abbvie Inc, Amgen, BMS, Eli Lilly, Gilead, Janssen, Novartis, Selecta, Scipher
Reviewer
Philip Masters, MD, FACP
Nothing to disclose